Integration Update: Leading Compliance Adherence

October 15, 2018

The Advarra team is proud to announce that all major integration activities are now complete. SOPs have been harmonized; staff...


An Introduction to Human Gene Transfer Research and Institutional Biosafety Committees (IBCs)

July 19, 2018

Advarra’s Director of Biosafety Services Daniel Eisenman discusses the basics of research involving genetic engineering and the role played by the IBC in conducting safe and responsible research.


Integration Update: Recent Milestones Completed

May 23, 2018

The Advarra team has worked to fully integrate our processes and policies to provide clients with unified capabilities and support...

Info Sheet

Advarra Services Overview

April 25, 2018

Advarra's integrated research compliance solutions help make your research altogether better.


Integration Update: Expanded FAQ for Advarra Merger Efforts

April 5, 2018

The Advarra team (formerly Chesapeake IRB and Schulman IRB) continues to integrate our processes and policies, leveraging mutual strengths in...


Integration Update: Revised FAQ for Advarra Merger Efforts

March 5, 2018

Since November 2017, the Advarra team (formerly Chesapeake IRB and Schulman IRB) has been working to integrate our processes and...


IBC vs. IRB: What’s the Difference?

September 22, 2017

Gene therapy research is exciting and full of promise, but because of the risks involved, it’s also highly regulated, requiring...


IRB-Connect Video

August 4, 2017

IRB-Connect allows seamless access for your data from Advarra's Center for IRB Intelligence (CIRBI) Platform to your eTMF.


Does This Study Require IBC Review?

June 29, 2017

One of the fastest growing areas in clinical research is clinical trials involving recombinant DNA, or gene therapy research. It’s...


Planning Gene Therapy Research? Plan for IBC Review

April 4, 2017

The completion of the human genome project and advances in genetic engineering have paved the way for clinical trials involving...